Consolidated Research GroupsEmerging Research GroupsAssociated Research Groups
Consolidated Research Groups
CO1: INMOX (Inflammation, Nutrition, Metabolism and Oxidative Stress)
CO2: Immunopathologies, Inflammatory Rheumatic Diseases and Biomarkers in Neoplastic Processes
CO3: Respiratory Diseases and Allergies
CO4: Neurodegeneration and Neurorepair
CO5: Neurogenesis and Neuroregeneration
CO6: Applied Cardiovascular and Proteomic Regenerative Therapy
CO7: Biomedical Engineering and Telemedicine
CO8: CTS1038 MOVE-IT Empowering Health by Physical Activity, Exercise and Nutrition
CO9: Neuropsychopharmacology and Psychobiology
CO10: Molecular Immunology and Gene and Cellular Immunotherapyr
CO11: NEUROTEK LAB
CO12: Neuroimaging and Psychophysiology
CO13: Infectious Diseases, Microbiology and Clinical Immunology
CO14: Physical Exercise and Health. Galeno Research Group
CO15: Population and Health: Determinants and Interventions
CO16: Genetics, Epigenetics and Transcription in Brain Diseases
CO17: Diabetes mellitus: Autoimmunity and chronic complications. Pathogenic, clinical, therapeutic and prognostic implications
CO18: Neurodegeneration and Alzheimer's disease (NeurAlz)
CO19: Psychological Well-being in Risk and Protective Contexts
CO20: Perinatal brain damage
CO22: Graphical Methods, Optimization and Learning (GOAL)
CO23: Genetics and Neurodegenerative Diseases
CO24: Nanotheranostics
CO25: Inflammation and metabolic syndrome in pregnancy
CO26: Epidemiology, quality of life and mhealth
CO27: Diagnosis in Cardiovascular Medicine. Circulating biomarkers and imaging tools
Emerging Research Groups
EM1: GADICOR
EM2: MathMed
EM3: Urological Oncology and tuberous sclerosis disease. Search for new therapeutic targets
EM4: Inflammation and metabolism during aging
EM5: DERMAhupm
EM6: Head and Neck Research
EM7: Bariatric and Metabolic Surgery: Clinical Studies and Experimental Models
EM8: Research in breast, ovarian, melanoma and lung cancer
EM10: Severe Mental Disorder
EM11: Uci-infectious
EM12: Biomedical Innovation in osteoarticular surgery
EM13: Clinical, epidemiological and translational research in Cancer
EM14: Research Group on Languages, Processes and Health Care Management
EM15: Health, sport and inflammation
EM16: Nutrition - Biomolecular, pathophysiological, clinical and socio-health aspects
EM18: Research, Development and Innovation in Maternal-Fetal Medicine and Gynecological Oncology
EM19: PHarmacy Analysis Researcher grOup (PHARO Group)
EM20: Oftalmo-Jerez
EM21: INPECA (Research in Pediatrics in Cádiz)
EM22: "Alcala" Vascular Risk Study in the province of Cádiz
EM23: Group for the Research and Optimization of Pharmacotherapy and the Analysis of Results (GIOFAR)
EM24: Group for the Investigation of Infectious Diseases of the province of Cádiz (GIPIC)
EM25: GIRESMO (Research Group for the Reduction of Stigma in Mental Health)
EM26: Pathobiology
EM27: Chronic inflammatory diseases of the airways “United Airways” (UNAIR)
EM29: Biomarkers
Associated Research Groups
IN1: Public Health and CVR Research Group in PHC” (GISPAP-RCV)
IN4: Research, Care and Health Outcomes iCURES
IN5: Mental Health Associated Research Group
IN10: Analysis and Design of Processes with Supercritical Fluids
IN11: Pathobiology of head and neck cancer and nasosinusal inflammatory disease
IN12: Biochemistry of Phosphate in the pathophysiology of blood
IN19: Biochemistry and Molecular Biology. Biotechnological Applications
IN23: Experimental Urology
IN25: Social and emotional neuropsychology
IN26: Oncology Research Group (CTS-237)
IN28: Research in Care
IN29: Anesthesia and Pain
IN30: Biomarkers of oxidative and nitrosative imbalance
IN31: Marine Natural Products Laboratory
IN34: Safety, Research and Innovation in Health Care (SIICS)
IN35: Vascular research applied to medicine and development
IN37: MATBIOMEDICINA
IN41: CTS-986 Physiotherapy and Health (FISA)
IN42: Serious infections, sepsis and systemic and cerebral inflammatory response
IN44: Acoustic Engineering Laboratory
IN46: Psychological, social and emotional factors linked to quality of life
IN48: Natural Products for drug development
IN49: Materials and Nanotechnology for innovation (TEP-946), INNANOMAT
IN50: Marine research applied to Public Health
IN51: SUAPJfrontera